Replies to post #90586 on Elite Pharmaceuticals Inc (ELTP)

[elichen]

LASERS, if they did go with method (1)--i.e. more shares/LPC/dilution--wouldn't that necessarily make the pps go down significantly in the short term, or whenever LPC old those shares?

If so, how much do you think it would go down? i.e. if currently $.045 for example?

[richme]

Lasers, many times I read that big pharma loved Elite but guess business is business and using the "big pharma loves Elite" served a useful purpose at the time. Of the three options you mentioned the LPC deal appears best to me since Elite already paid the upfront costs and likely can't not recover the amounts advanced. So unless a better deal comes up that on balance offsets any potential losses on the LPC deal why not stay with it. It is possible also that since the LPC deal is already on the books NH's intent is to tap it and other sources as well and that is why he see the need to revisit the shares situation later.

[jpc7330]

I would much rather vote for an increase in the A/S and get a whole line of products out than a R/S. With an increase in the A/S and products launched, ELTP could always buy back shares. ELTP only has $4M in debt! The A/S count shouldn't scare off investors if we have the products to support the share count. PFE, C, BAC all have billions of shares and 800M A/S, O/S for ELTP in a $27B+ industry is nothing! Next CC I will ask if the option of increasing the A/S and not a R/S would be better for all especially if the ART products get launched.